The final event of the European project FIRST2RUN will take place at the Square Convention centre in Brussels on June 20. Co-ordinated by Italian biochemical company Novamont and funded by the Bio-Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme, FIRST2RUN is a flagship project involving four companies and universities from Italy, UK and The Netherlands.
EFIB returns to Brussels. From 30th September to 2nd October the European Forum for Industrial Biotechnology and the Biobased Economy (EFIB) returns to Europe’s capital, where it was first launched 5 years ago. Since then, the event has grown tenfold in size but remains true to its goal of providing the premier meeting place for business and policy throughout the biobased value chain.
“We believe that EFIB (European Forum for Industrial Biotechnology and Bio-based Economy, editor’s note), taking place during the first European Biotech Week, contributes to increase the awareness of Europeans to the bioeconomy.” To say it is Nathalie Moll, Secretary General of EuropaBio, The European Association for Bioindustries, one of the organizers, with Smithers Rapra, of the event which will be held in Brussels from 30 September to 2 October. In this interview with Il Bioeconomista, Moll talks about EFIB – “a single platform for European business leaders, innovators and policymakers to meet, discuss and shape the future of the bioeconomy” – and the latest development of European Bioeconomy, focusing on the Public Private Partnership for Biobased industries (Bridge), “a multisector initiative whose vision is that of a society and economy which increasingly makes everyday products, such as food, feed, textiles, chemicals and fuels, from locally sourced biomass and wastes, rather than from fossil fuels.”
Interview by Mario Bonaccorso